Demographic characteristics of Latin American patients with CGD (n = 238)
| . | Total . | XL-CGD . | AR-CGD . | AR-CGD + UGfem . | UG-CGD . |
|---|---|---|---|---|---|
| No. of patients, n (%) | 238 (100) | 109 (46) | 32 (13) | 52 (29) | 97 (41) |
| Family, n | 210 | 94 | 28 | 47 | 88 |
| Consanguinity, n (%) | 22 (10) | 3 (3) | 13 (46) | 14 (30) | 6 (6.2) |
| Family history of CGD, n (%) | 41 (19) | 22 (23) | 5 (18) | 8 (17) | 14 (14.4) |
| Outcome | |||||
| Undergoing HSTC, n (%) | 53 (22) | 22 (20) | 5 (16) | 8 (15) | 26 (26.8) |
| HSCT deceased, n (%) | 16 (30) | 7 (31) | 2 (40) | 2 (25) | 7 (27) |
| Deceased, n (%) | 80 (34) | 43 (54)* | 4 (5) | 12 (15)* | 33 (34) |
| Age of death | 66m (1m–31y2m) | 60.5m (5m–31y2m) | 133.5m (2 years–19y6m) | 88m (1y5m–23y) | 75m (1m–25y) |
| . | Total . | XL-CGD . | AR-CGD . | AR-CGD + UGfem . | UG-CGD . |
|---|---|---|---|---|---|
| No. of patients, n (%) | 238 (100) | 109 (46) | 32 (13) | 52 (29) | 97 (41) |
| Family, n | 210 | 94 | 28 | 47 | 88 |
| Consanguinity, n (%) | 22 (10) | 3 (3) | 13 (46) | 14 (30) | 6 (6.2) |
| Family history of CGD, n (%) | 41 (19) | 22 (23) | 5 (18) | 8 (17) | 14 (14.4) |
| Outcome | |||||
| Undergoing HSTC, n (%) | 53 (22) | 22 (20) | 5 (16) | 8 (15) | 26 (26.8) |
| HSCT deceased, n (%) | 16 (30) | 7 (31) | 2 (40) | 2 (25) | 7 (27) |
| Deceased, n (%) | 80 (34) | 43 (54)* | 4 (5) | 12 (15)* | 33 (34) |
| Age of death | 66m (1m–31y2m) | 60.5m (5m–31y2m) | 133.5m (2 years–19y6m) | 88m (1y5m–23y) | 75m (1m–25y) |
General demographic characteristics of Latin American CGD patients by genotype/phenotype (XL-CGD, AR-CGD, AR-CGD + UGfem, and UG-CGD) and total. For statistical purposes, UGfem were included in the AR-CGD group, forming the group AR-CGD + UGfem. y, year; m, month. *χ2 test (P = 0.041).